Clearstead Advisors’s Microbot Medical MBOT Stock Holding History

Clearstead Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$663	Hold	275	–	–	﹤0.01%	2093
2025 Q4	$550	Buy	+275	New	+$651	﹤0.01%	2300

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Clearstead Advisors's MBOT Position: Q1 2026 in Review

Clearstead Advisors held its Microbot Medical (MBOT) position steady in Q1 2026 at 275 shares worth $663. The position accounts for ﹤0.01% of the portfolio, ranked #2093.

Clearstead Advisors first reported a position in MBOT in Q4 2025 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

Clearstead Advisors held 275 shares of Microbot Medical worth $663 as of Q1 2026.
Clearstead Advisors left its Microbot Medical share count unchanged in Q1 2026.
Microbot Medical made up ﹤0.01% of Clearstead Advisors's portfolio in Q1 2026, its #2093 holding.
Clearstead Advisors first reported a position in Microbot Medical in Q4 2025 and has held it in 2 quarters since.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.